Abstract
The objective of this research was to explore the effect of metformin on the lipoteichoic acid (LTA)–induced mastitis model using isolated primary bovine mammary epithelial cells (PBMECs). The PBMECs were exposed to either 3 mM metformin for 12 h as a metformin group (MET) or 100 μg/mL LTA for 6 h as LTA group (LTA). Cells pretreated with 3 mM metformin for 12 h followed by washing and 100 μg/mL LTA exposure for 6 h served as the MET + LTA group. Phosphate-buffered saline was added to cells as the control group. PBMECs pretreated with different metformin doses were analyzed by a flow cytometry (annexin V–fluorescein isothiocyanate assay) to detect the cell apoptotic rate. We performed quantitative reverse transcriptase–polymerase chain reaction and Western blot analysis to evaluate the inflammatory and oxidative responses to metformin and LTA by measuring cellular cytotoxicity, mRNA expression, and protein expression. Immunofluorescence was used to evaluate nuclear localization. The results showed that the gene expression of COX2, IL-1β, and IL-6 significantly increased in the cells challenged with LTA doses compared to control cells. In inflammatory PBMECs, metformin attenuated LTA-induced expression of inflammatory genes nuclear factor κB (NF-κB) p65, tumor necrosis factor α, cyclooxygenase 2, and interleukin 1β, as well as the nuclear localization and phosphorylation of NF-κBp65 protein, but increased the transcription of nuclear factor erythroid 2–related factor 2 (Nrf2) and Nrf2-targeted antioxidative genes heme oxygenase-1 (HO-1) and Gpx1, as well as the nuclear localization of HO-1 protein. Importantly, metformin-induced activation of Nrf2 is AMP-activated protein kinase (AMPK)–dependent; as metformin-pretreated PBMECs activated AMPK signaling via the upregulation of phosphorylated AMPK levels, cell pretreatment with metformin also reversed the translocation of Nrf2 that was LTA inhibited. This convergence between AMPK and Nrf2 pathways is essential for the anti-inflammatory effect of metformin in LTA-stimulated PBMECs. Altogether, our results indicate that metformin exerts anti-inflammation and oxidative stress through regulation of AMPK/Nrf2/NF-κB signaling pathway, which highlights the role of AMPK as a potential therapeutic strategy for treatment of bovine mastitis.
Highlights
Mastitis is a frequent and costly bovine mammary disease in the milk production industry [1], which seriously affects animal health and production ability and causes a huge economic loss to the dairy industry [2]
nuclear factor erythroid 2–related factor 2 (Nrf2) at the protein level was decreased in the primary bovine mammary epithelial cells (PBMECs) challenged with Lipoteichoic acid (LTA)
The results of this study indicated the effect of Met on Nrf2 protein in PBMECs induced by LTA, and it may provide an opportunity for a new mechanism on functional molecules capable of interfering with the binding and activation of the Nrf2 pathway
Summary
Mastitis is a frequent and costly bovine mammary disease in the milk production industry [1], which seriously affects animal health and production ability and causes a huge economic loss to the dairy industry [2]. Lipoteichoic acid (LTA), a bacterial endotoxin embedded in the cytoderm of S. aureus, is a critical factor known to activate inflammatory responses [6] and affect lactation in the mammary gland of cows [7, 8]. Evidence shows that AMPK activation can decrease oxidative stress and inhibit inflammation [12]. NF-κB and mitogen-activated protein kinase signaling pathways regulate cytokines and chemokine expression, which are essential immune mediators during inflammation [14]. The AMPK pathway shares distinct crosstalk with the antioxidant response, nuclear factor erythroid 2–related factor 2 (Nrf). Many studies have supported the notion that the Nrf antioxidant pathway is downstream to AMPK [18, 19]. Whether AMPK plays a positive action in inhibiting oxidative stress and inflammation in bovine mammary epithelial cells (BMECs) remains unknown
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.